+1.62%

S&O 500 5,382.45

-0.47%

US 10 400

+2.28%

Nasdaq 16,565.41

+2.28%

Crude Oil 16,565.41

-0.27%

FTSE 100 8,144.87

+1.06%

Gold 2,458.10

-0.53%

Euro 1.09

+0.36%

Pound/Dollar 1.27

Thursday, November 19, 2026

Hims & Hers launches Peptides+ treatments

by marketdash
0 comments

Hims & Hers peptide treatments.

Courtesy: Hims & Hers

Hims & Hers Health on Wednesday said it will offer five formulations of peptides and longevity treatments compounded in the U.S. as part of the initial rollout of its Peptides+ platform, all of which are not approved by regulators.

Even as it announced the new products, Hims & Hers acknowledged it has more to learn about how best to use the peptides and how effective they are — underscoring the uncertainty surrounding the growing space.

The new offerings come after the federal government eased restrictions on compounding certain unapproved peptides, which are short chains of amino ​acids. Those products have exploded in popularity among fitness and longevity enthusiasts who attest that they help with muscle growth, rapid injury recovery and anti-aging, even though most lack evidence from robust human trials.

Hims in late October launched an early access list for the upcoming…

Read more…

You may also like

Get New Updates nto Take Care Your Pet

Discover the art of creating a joyful and nurturing environment for your beloved pet.

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Will be used in accordance with our Privacy Policy

@ 2024 – Marketdash – All Rights Reserved.